Alert detail
LCD L37033: MolDX: DecisionDx-UM (Uveal Melanoma) — Palmetto GBA
What changed
MolDX LCD covers DecisionDx-UM gene test for uveal melanoma risk.
Who’s affected: Oncology billing teams · Effective: June 30, 2022
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 6 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.